Why the study?
Do homologous and heterologous antibody preparations prevent symptomatic disease in a mouse model of rotavirus infection?
Do homologous and heterologous antibody preparations prevent symptomatic disease in a mouse model of rotavirus infection?
Homologous antibodies and certain immunoglobulins from other sources can neutralize murine rotavirus and prevent symptomatic disease in infant mice, while allowing for the generation of an active immune response.
Answers are grounded in this paper and cite their sources.
May inform strain-specific rotavirus interventions; hypothesis-generating and should not yet change practice.
We investigated the abilities of homologous and heterologous antibody preparations to neutralize murine rotavirus in a mouse model of rotavirus infection. We found that incubation of virus with murine sera obtained from animals experimentally infected with the homologous epizootic diarrhea of infant mice strain of rotavirus resulted in inability of the virus to cause symptomatic disease in infant mice. Sera from nonimmune mice and mice infected or immunized with a heterotypic strain of rotavirus did not effectively neutralize virus in this system. On the other hand, neutralization was noted after incubation of virus with a number of immunoglobulins from other animal and human sources. The neutralizing activity of the preparations in the murine model correlated partially, but not completely, with the level of in vitro neutralizing antibody to the murine strain of rotavirus measured in a tissue culture system. In most cases, asymptomatic infection after feeding of the virus and the antibody preparation resulted in subsequent generation of an active immune response in infected animals.
No takes yet. Share an insight, caveat, or question.
Losonsky et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: